Abbott DBS Post-Market Study of Outcomes for Indications Over Time
Status: Recruiting
Location: See all (48) locations...
Intervention Type: Device
Study Type: Observational
SUMMARY
The purpose of this international study is to evaluate long-term safety and effectiveness of Abbott deep brain stimulation (DBS) systems for all indications, including Parkinson's disease, essential tremor or other disabling tremor and dystonia.
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• Subject is scheduled for a new implant or IPG device replacement surgery with a market-released Abbott DBS system within 180 days.
• Subject, or a legally acceptable representative, must provide written informed consent prior to any study-related procedure.
Locations
United States
Arizona
University of Aizona Health Sciences
ACTIVE_NOT_RECRUITING
Tucson
California
Cedars-Sinai Medical Center
ACTIVE_NOT_RECRUITING
Los Angeles
University of California at Davis
ACTIVE_NOT_RECRUITING
Sacramento
Colorado
Colorado Neurodiagnostics
TERMINATED
Littleton
Neurosurgery One
WITHDRAWN
Littleton
Florida
University of Miami Hospital
ACTIVE_NOT_RECRUITING
Miami
University of South Florida - Department of Neurology
RECRUITING
Tampa
Illinois
Rush University Medical Center
RECRUITING
Chicago
Indiana
Indiana University
RECRUITING
Indianapolis
Kansas
Kansas University Medical Center
ACTIVE_NOT_RECRUITING
Kansas City
Kentucky
University of Louisville
RECRUITING
Louisville
Louisiana
Willis-Knighton Medical Center
TERMINATED
Shreveport
Massachusetts
Beth Israe Deaconess Medical Center
ACTIVE_NOT_RECRUITING
Boston
New Hampshire
Dartmouth Hitchcock Medical Center
ACTIVE_NOT_RECRUITING
Lebanon
New York
Albany Medical Center
RECRUITING
Albany
Ohio
The Cleveland Clinic Foundation
RECRUITING
Cleveland
Ohio State Medical
RECRUITING
Columbus
Wright State University & Premier Health
WITHDRAWN
Fairborn
Pennsylvania
Center for Interventional Pain & Spine
WITHDRAWN
Exton
Thomas Jefferson Department or Neurosurgery
ACTIVE_NOT_RECRUITING
Philadelphia
Allegheny General Hospital Department of Neurosurgery
TERMINATED
Pittsburgh
Texas
Texas Movement Disorder Specialist
ACTIVE_NOT_RECRUITING
Georgetown
Utah
University of Utah Hospital
RECRUITING
Salt Lake City
Other Locations
Australia
Royal Melbourne Hospital - City Campus
RECRUITING
Parkville
Princess Alexandra Hospital
RECRUITING
Woolloongabba
Finland
Helsinki University Central Hospital
RECRUITING
Helsinki
France
CHU Gabriel Montpied
WITHDRAWN
Clermont-ferrand
CHU Hopital Pasteur
RECRUITING
Nice
Fondation Rothchild
WITHDRAWN
Paris
CHU de St Etienne
ACTIVE_NOT_RECRUITING
Saint-etienne
Germany
Medizinische Einrichtungen der Universität Düsseldorf
RECRUITING
Düsseldorf
UKE Hamburg (Universitatsklinik Eppendorf)
ACTIVE_NOT_RECRUITING
Hamburg
Universitätsklinikum des Saarlandes
RECRUITING
Homburg
UNIVERSITATSMEDIZIN der Johannes Gutenberg-Universität Mainz
RECRUITING
Mainz
Universitätsklinikum Münster
RECRUITING
Münster
Universitäts Klinikum Tübingen
RECRUITING
Tübingen
Italy
Az.Osp. Universitaria di Ferrara
TERMINATED
Cona
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
ACTIVE_NOT_RECRUITING
Milan
Policlinico Universitario A. Gemelli
RECRUITING
Rome
Spain
Hospital Universitari Germans Trias I Pujol
RECRUITING
Badalona
Hospital Universitario de la Princesa
RECRUITING
Madrid
Hospital Virgen de Rocio
RECRUITING
Seville
Taiwan
Hualien Tzu Chi Hospital
RECRUITING
Hualien City
Chang Gung Memorial Hospital
ACTIVE_NOT_RECRUITING
Linkou District
United Kingdom
Southmead Hospita
WITHDRAWN
Bristol
Queen Elizabeth University Hospital
RECRUITING
Glasgow
The Walton Centre
ACTIVE_NOT_RECRUITING
Liverpool
King's College Hospital
RECRUITING
London
Contact Information
Primary
Claudia Salazar, PhD
claudia.salazar4@abbott.com
+1-650-647-3396
Backup
Shirisha Chiluka
Shirisha.Chiluka@abbott.com
972-526-4820
Time Frame
Start Date: 2019-11-26
Estimated Completion Date: 2030-09
Participants
Target number of participants: 1000
Treatments
Deep brain stimulation
Subjects implanted with an Abbott DBS system
Authors
Related Therapeutic Areas
Sponsors
Leads: Abbott Medical Devices